C-MER Eye Care Holdings Limited
HKEX:3309.HK
1.83 (HKD) • At close July 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,913.162 | 1,923.964 | 1,731.903 | 1,112.577 | 699.545 | 576.209 | 429.374 | 311.228 | 248.659 | 198.851 | 156.472 |
| Cost of Revenue
| 1,385.543 | 1,305.002 | 1,366.56 | 803.137 | 535.898 | 392.655 | 280.037 | 175.797 | 153.683 | 119.15 | 97.429 |
| Gross Profit
| 527.619 | 618.962 | 365.343 | 309.44 | 163.647 | 183.554 | 149.337 | 135.431 | 94.976 | 79.701 | 59.043 |
| Gross Profit Ratio
| 0.276 | 0.322 | 0.211 | 0.278 | 0.234 | 0.319 | 0.348 | 0.435 | 0.382 | 0.401 | 0.377 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 342.585 | 354.928 | 345.347 | 234.115 | 139.276 | 98.423 | 64.867 | 43.584 | 29.846 | 26.094 | 27.526 |
| Selling & Marketing Expenses
| 133.39 | 147.802 | 126.774 | 126.442 | 69.885 | 46.3 | 26.501 | 11.263 | 7.874 | 4.694 | 2.918 |
| SG&A
| 475.975 | 502.73 | 389.774 | 311.769 | 177.368 | 135.69 | 91.368 | 54.847 | 37.72 | 30.788 | 30.444 |
| Other Expenses
| 117.805 | -3.105 | 0.626 | 0.336 | 0.552 | 1.698 | 0.482 | 0.914 | -0.062 | 0.024 | -0.018 |
| Operating Expenses
| 593.78 | 499.625 | 389.774 | 311.769 | 177.368 | 135.69 | 101.408 | 77.267 | 37.658 | 30.812 | 30.426 |
| Operating Income
| -66.161 | 119.337 | -24.431 | -2.329 | -13.721 | 47.864 | 58.84 | 82.114 | 59.528 | 49.62 | 28.929 |
| Operating Income Ratio
| -0.035 | 0.062 | -0.014 | -0.002 | -0.02 | 0.083 | 0.137 | 0.264 | 0.239 | 0.25 | 0.185 |
| Total Other Income Expenses Net
| -10.06 | 4.932 | -15.45 | -8.52 | -5.572 | 5.54 | 3.197 | -23.628 | 1.278 | -0.458 | -0.654 |
| Income Before Tax
| -76.221 | 124.269 | -49.026 | 16.223 | 2.78 | 53.404 | 61.166 | 58.486 | 58.596 | 48.431 | 27.963 |
| Income Before Tax Ratio
| -0.04 | 0.065 | -0.028 | 0.015 | 0.004 | 0.093 | 0.142 | 0.188 | 0.236 | 0.244 | 0.179 |
| Income Tax Expense
| 32.093 | 37.934 | 34.998 | 10.645 | 10.916 | 14.086 | 18.595 | 18.359 | 11.709 | 10.074 | 5.602 |
| Net Income
| -135.163 | 61.998 | -21.875 | 21.861 | -6.246 | 41.435 | 42.571 | 40.127 | 46.887 | 38.357 | 22.361 |
| Net Income Ratio
| -0.071 | 0.032 | -0.013 | 0.02 | -0.009 | 0.072 | 0.099 | 0.129 | 0.189 | 0.193 | 0.143 |
| EPS
| -0.11 | 0.049 | -0.018 | 0.019 | -0.006 | 0.04 | 0.042 | 0.052 | 0.047 | 0.038 | 0.022 |
| EPS Diluted
| -0.11 | 0.049 | -0.018 | 0.019 | -0.006 | 0.039 | 0.04 | 0.052 | 0.047 | 0.038 | 0.022 |
| EBITDA
| 209.183 | 359.882 | 194.311 | 177.799 | 126.694 | 139.474 | 84.386 | 90.692 | 69.736 | 60.467 | 39.588 |
| EBITDA Ratio
| 0.109 | 0.187 | 0.112 | 0.16 | 0.181 | 0.242 | 0.197 | 0.291 | 0.28 | 0.304 | 0.253 |